Yasutaka Takeda

Antiangiogenic and Antitumor Activities of IL-27

Motomu Shimizu, Mariko Shimamura, Toshiyuki Owaki et al. · The Journal of Immunology · 2006 · 175 citations · Full text

Medicine, Immunology, Oncology +17

Induction of Antitumor Immunity with Fas/APO-1 Ligand (CD95L)-Transfected Neuroblastoma Neuro-2a Cells

Motomu Shimizu, A. Fontana, Yasutaka Takeda et al. · The Journal of Immunology · 1999 · 88 citations · Full text

Life Sciences, Immunology, Oncology +17

Characteristics and prognosis of Japanese female breast cancer patients: The BioBank Japan project

Koshi Nakamura, Emiko Okada, Shigekazu Ukawa et al. · Journal of Epidemiology · 2017 · 34 citations · Full text

Medicine, Oncology, Pathology +16

Survival of leukemic cells in a dormant state following cyclophosphamide‐induced cure of strongly immunogenic mouse leukemia (DL811)

Akio Matsuzawa, Yasutaka Takeda, Mutsumi Narita et al. · International Journal of Cancer · 1991 · 20 citations

Medicine, Immunology, Oncology +16

Fas/Apo-1 (CD95)-Mediated Apoptosis of Neutrophils with Fas Ligand (CD95L)-Expressing Tumors Is Crucial for Induction of Inflammation by Neutrophilic Polymorphonuclear Leukocytes Associated with Antitumor Immunity

Motomu Shimizu, A. Fontana, Yasutaka Takeda et al. · Cellular Immunology · 2001 · 19 citations

Life Sciences, Immunology, Oncology +16